340 related articles for article (PubMed ID: 30350935)
21. Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.
Hirschfeld M; Rücker G; Weiß D; Berner K; Ritter A; Jäger M; Erbes T
Mol Diagn Ther; 2020 Apr; 24(2):215-232. PubMed ID: 32112368
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous and multiplexed detection of exosome microRNAs using molecular beacons.
Lee JH; Kim JA; Jeong S; Rhee WJ
Biosens Bioelectron; 2016 Dec; 86():202-210. PubMed ID: 27372573
[TBL] [Abstract][Full Text] [Related]
23. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
Joyce DP; Kerin MJ; Dwyer RM
Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.
Liu W; Chen S; Liu B
Pediatr Surg Int; 2016 Nov; 32(11):1059-1065. PubMed ID: 27601233
[TBL] [Abstract][Full Text] [Related]
25. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
26. Synergy of Peptide-Nucleic Acid and Spherical Nucleic Acid Enabled Quantitative and Specific Detection of Tumor Exosomal MicroRNA.
Liu L; Lu H; Shi R; Peng XX; Xiang Q; Wang B; Wan QQ; Sun Y; Yang F; Zhang GJ
Anal Chem; 2019 Oct; 91(20):13198-13205. PubMed ID: 31553171
[TBL] [Abstract][Full Text] [Related]
27. Upregulated Expression of Serum Exosomal microRNAs as Diagnostic Biomarkers of Lung Adenocarcinoma.
Feng M; Zhao J; Wang L; Liu J
Ann Clin Lab Sci; 2018 Nov; 48(6):712-718. PubMed ID: 30610040
[TBL] [Abstract][Full Text] [Related]
28. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
29. Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors.
Gonzalez-Villasana V; Rashed MH; Gonzalez-Cantú Y; Bayraktar R; Menchaca-Arredondo JL; Vazquez-Guillen JM; Rodriguez-Padilla C; Lopez-Berestein G; Resendez-Perez D
Dis Markers; 2019; 2019():6852917. PubMed ID: 30891102
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
31. In Situ Exosomal MicroRNA Determination by Target-Triggered SERS and Fe
Jiang S; Li Q; Wang C; Pang Y; Sun Z; Xiao R
ACS Sens; 2021 Mar; 6(3):852-862. PubMed ID: 33555177
[TBL] [Abstract][Full Text] [Related]
32. Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes.
Joshi GK; Deitz-McElyea S; Liyanage T; Lawrence K; Mali S; Sardar R; Korc M
ACS Nano; 2015 Nov; 9(11):11075-89. PubMed ID: 26444644
[TBL] [Abstract][Full Text] [Related]
33. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
34. Exosomal microRNA: a novel biomarker for breast cancer.
He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
[TBL] [Abstract][Full Text] [Related]
36. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
Schwarzenbach H
Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea.
Kim J; Park S; Hwang D; Kim SI; Lee H
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32659906
[No Abstract] [Full Text] [Related]
38. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
39. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
40. High-Discrimination Factor Nanosensor Based on Tetrahedral DNA Nanostructures and Gold Nanoparticles for Detection of MiRNA-21 in Live Cells.
Bai S; Xu B; Guo Y; Qiu J; Yu W; Xie G
Theranostics; 2018; 8(9):2424-2434. PubMed ID: 29721089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]